Blogs

Improving IRBs: A Case Study with Copernicus Group IRB

ByDawn Pope

March 27th 2013

Applied Clinical Trials

Does a "Poisonous Fog" Hang Over Clinical Trials for Anti-Depressants?

ByEdna Astbury-Ward, PhD

March 26th 2013

Applied Clinical Trials

Clinical Trials Are Slow at Adopting Change

ByMoe Alsumidaie

March 26th 2013

Applied Clinical Trials

European Medicines Agency Still Struggling with its Accounts

ByPeter O'Donnell, ACT's Brussels Correspondent

March 21st 2013

Applied Clinical Trials

eClinical Immersion, 2

March 18th 2013

Applied Clinical Trials

CDER Runs into Trouble with Generic Drug Reorg Plan

ByJill Wechsler, ACT's Washington Correspondent

March 15th 2013

Applied Clinical Trials

Sequestration: How Big a Hit for FDA, Research and Pharma?

ByJill Wechsler, ACT's Washington Correspondent

March 12th 2013

Applied Clinical Trials

Transparency to Alter Sponsor-CRO Relations

ByJill Wechsler, ACT's Washington Correspondent

March 8th 2013

Applied Clinical Trials

ISR Reports Breaks Down: 2013 Late Phase Market Overview and Outlook

ByJeremy Klein

March 7th 2013

Applied Clinical Trials

The Patient Recruitment Secret (for Sponsors and CROs)

ByRahlyn Gossen

March 4th 2013

Applied Clinical Trials

Testing Times for Clinical Trials in Europe

March 1st 2013

Applied Clinical Trials

European Commission's proposed system faces scrutiny from three separate committees.

Countdown Time for IMI?

ByPeter O'Donnell, ACT's Brussels Correspondent

February 28th 2013

Applied Clinical Trials

eClinical Immersion

ByLisa Henderson

February 27th 2013

Applied Clinical Trials

Data Doubts Cloud Europe's Clinical Trials Hopes

ByPeter O'Donnell, ACT's Brussels Correspondent

February 21st 2013

Applied Clinical Trials

What Dedication Looks Like

ByLisa Henderson

February 19th 2013

Applied Clinical Trials

Small Clinical Trials Feasible for New Limited-Population Approval Pathway

ByJill Wechsler, ACT's Washington Correspondent

February 19th 2013

Applied Clinical Trials

Resolving The Conflict Over Surging Clinical Trial Costs & Sluggish Enrollment

ByMoe Alsumidaie

February 14th 2013

Applied Clinical Trials

Phase I Trials Take on Greater Budgetary Importance

ByLisa Henderson

February 6th 2013

Applied Clinical Trials

Bringing Brussels and Africa Closer on Trials

February 1st 2013

Applied Clinical Trials

Researchers from sub-Saharan countries are going to have better chances of upgrading their skills.

Are E-Patients Overwhelmed?

ByPeter O'Donnell, ACT's Brussels Correspondent

January 31st 2013

Applied Clinical Trials

2013 - The Year the Clinical Research Industry Adopts Accredited Training?

ByMartin Robinson

January 28th 2013

Applied Clinical Trials

The Dangers of Media Misreporting Medicines

ByPeter O'Donnell, ACT's Brussels Correspondent

January 28th 2013

Applied Clinical Trials

Medical Translation in Clinical Research

ByDavid Grunwald

January 24th 2013

Applied Clinical Trials

Will "Robust Pipeline" Yield More New Drugs?

ByJill Wechsler, ACT's Washington Correspondent

January 21st 2013

Applied Clinical Trials

An Inside Look at ClinTech 2013

January 17th 2013

Applied Clinical Trials

The Gamification of Clinical Trials: What's Next?

ByRahlyn Gossen

January 17th 2013

Applied Clinical Trials

Improving Clinical Trial Quality & Productivity at Investigative Sites

ByMoe Alsumidaie

January 16th 2013

Applied Clinical Trials

ISR's "Social Media: Best Practices and Strategic Use in Patient Recruitment"

ByJeremy Klein

January 10th 2013

Applied Clinical Trials

Looking Back - and Forward

ByPeter O'Donnell, ACT's Brussels Correspondent

January 3rd 2013

Applied Clinical Trials

A Little Light in a Dark Europe

ByPeter O'Donnell, ACT's Brussels Correspondent

January 2nd 2013

Applied Clinical Trials

Blogs

Improving IRBs: A Case Study with Copernicus Group IRB

Does a "Poisonous Fog" Hang Over Clinical Trials for Anti-Depressants?

Clinical Trials Are Slow at Adopting Change

European Medicines Agency Still Struggling with its Accounts

eClinical Immersion, 2

CDER Runs into Trouble with Generic Drug Reorg Plan

Sequestration: How Big a Hit for FDA, Research and Pharma?

Transparency to Alter Sponsor-CRO Relations

ISR Reports Breaks Down: 2013 Late Phase Market Overview and Outlook

The Patient Recruitment Secret (for Sponsors and CROs)

Testing Times for Clinical Trials in Europe

Countdown Time for IMI?

eClinical Immersion

Data Doubts Cloud Europe's Clinical Trials Hopes

What Dedication Looks Like

Small Clinical Trials Feasible for New Limited-Population Approval Pathway

Resolving The Conflict Over Surging Clinical Trial Costs & Sluggish Enrollment

Phase I Trials Take on Greater Budgetary Importance

Bringing Brussels and Africa Closer on Trials

Are E-Patients Overwhelmed?

2013 - The Year the Clinical Research Industry Adopts Accredited Training?

The Dangers of Media Misreporting Medicines

Medical Translation in Clinical Research

Will "Robust Pipeline" Yield More New Drugs?

An Inside Look at ClinTech 2013

The Gamification of Clinical Trials: What's Next?

Improving Clinical Trial Quality & Productivity at Investigative Sites

ISR's "Social Media: Best Practices and Strategic Use in Patient Recruitment"

Looking Back - and Forward

A Little Light in a Dark Europe

Trending on Applied Clinical Trials Online

Vaccine Trials at an Inflection Point: Operational, Regulatory, and Public Trust Challenges

What Real-Time Data Review Actually Demands of Sponsors and CROs

ACT Brief: Cross-Asset Site Partnerships, Vaccine Trial Standardization, and Ovarian Cancer Care Gaps

The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck

Accelerating patient recruitment: Connecting the right patients to the right trial